▼ Summary
– Dr. William Kapp co-founded Fountain Life after being inspired by discussions on genomics and longevity tech at a medical conference.
– Fountain Life focuses on early disease detection, health optimization, and regenerative therapies through advanced screening and AI-powered tracking.
– The company recently raised an $18M Series B, totaling $108M in funding, to expand its network of longevity centers.
– Fountain Life’s services are expensive, with annual memberships costing up to $21,500, but have successfully detected serious conditions like cancer and aneurysms early.
– Competitors like Function Health offer cheaper alternatives but lack physician access and comprehensive scans, though they are expanding their services.
Longevity-focused healthcare company Fountain Life has secured $18 million in Series B funding, marking another milestone in its mission to revolutionize preventive medicine. The investment, led by EOS Ventures with participation from existing board members, brings the firm’s total funding to approximately $108 million since its inception.
The company traces its origins to a pivotal moment in 2016 when orthopedic surgeon Dr. William Kapp attended a medical conference featuring innovators like Dr. Peter Diamandis and stem-cell pioneer Dr. Bob Hariri. Inspired by discussions on genomics and cutting-edge health technologies, Kapp returned to Naples, Florida, and launched the Longevity Performance Center, a precursor to Fountain Life. The venture caught the attention of Diamandis and motivational speaker Tony Robbins, who later merged their stem-cell startup, Fountain Therapeutics, with Kapp’s initiative in 2020.
Today, Fountain Life operates four clinics across the U.S., with plans to expand to Houston, Los Angeles, and Miami by 2026. The company’s approach revolves around three core principles: early disease detection, health optimization, and regenerative therapies. Members undergo quarterly screenings that analyze over 100 biomarkers, from liver health to microbiome balance, using advanced blood tests and full-body scans. Results are tracked through Zori, an AI-powered app that provides personalized insights.
While the service comes at a premium, $21,500 annually for comprehensive testing and physician access, Kapp emphasizes its life-saving potential. Early screenings have detected conditions like kidney cancer and brain aneurysms in asymptomatic patients, enabling timely interventions. To address affordability, Fountain Life is exploring partnerships with medical facilities to train them in its methodologies, aiming to democratize access over time.
The longevity sector is gaining traction, with competitors like Function Health, founded by Dr. Mark Hyman, offering more affordable testing packages. However, Fountain Life distinguishes itself with its integrated physician support and regenerative therapy options. As the company scales, its focus remains on bridging the gap between cutting-edge science and real-world healthcare solutions.
(Source: TechCrunch)